ruthenium has been researched along with thiazoles in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Mitchell, P; Mitchell, R; Moody, AJ; West, IC | 1 |
| Kang, JS; Lakowicz, JR; Piszczek, G | 1 |
| Buyukliev, R; Ivanov, D; Karaivanova, M; Konstantinov, S; Nikolova, A | 1 |
| El-Bindary, AA; El-Dissouky, A; El-Gogary, TM; El-Sonbati, AZ; Hilali, AS | 1 |
| Arion, VB; Fremuth, M; Jakupec, MA; Keppler, BK; Kukushkin, VY; Pombeiro, AJ; Reisner, E | 1 |
| James, BR; Kennedy, DC; Patrick, BO; Wu, A | 1 |
| Camalli, M; Corsini, M; Messori, L; Mura, P; Piccioli, F; Zanello, P | 1 |
| Bontchev, P; Buyukliev, R; Gochev, G; Ivanov, D; Karaivanova, M; Konstantinov, S; Mehandjiev, D; Nikolova, A | 1 |
| Cadet, JL; Chen, J; Deng, X; Errico, S; Freed, WJ; Lee, CT | 1 |
| Camalli, M; Gabbiani, C; Messori, L; Mura, P; Piccioli, F | 1 |
| Casini, A; Casolaro, M; Cini, R; Defazio, S; Hursthouse, M; Messori, L; Morpurgo, M; Tamasi, G | 1 |
| Chen, IT; Roethle, PA; Trauner, D | 1 |
| Grubbs, RH; Vougioukalakis, GC | 1 |
| Ilardi, EA; Zakarian, A | 1 |
| Cohrt, AE; Nielsen, TE | 1 |
| Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Cheminel, T; Grozav, A; Therrien, B | 1 |
| Chung, YJ; Lee, BI; Park, CB; Son, G | 1 |
| Ding, Q; Ge, J; Jiang, Z; Liu, D; Luo, P; Peng, Y | 1 |
| Bothwell, PJ; Fisher, SS; Hamaker, CG; Huffman, SE; Jones, MA; Platt, DC; Webb, MI; Yawson, GK | 1 |
19 other study(ies) available for ruthenium and thiazoles
| Article | Year |
|---|---|
Proton translocation by cytochrome oxidase in (antimycin + myxothiazol)-treated rat liver mitochondria using ferrocyanide or hexammineruthenium as electron donor.
Topics: Animals; Antimycin A; Electron Transport Complex IV; Ferrocyanides; Methacrylates; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Rats; Rotenone; Ruthenium; Ruthenium Compounds; Thiazoles | 1986 |
On the possibility of long-wavelength long-lifetime high-quantum-yield luminophores.
Topics: Acridine Orange; Animals; Carbocyanines; Cattle; DNA; Energy Transfer; Ethidium; Fluorescence; Fluorescent Dyes; Half-Life; Infrared Rays; Intercalating Agents; Kinetics; Luminescent Measurements; Molecular Structure; Organometallic Compounds; Phenazines; Ruthenium; Thiazoles | 2001 |
Preparation, physicochemical characterization and pharmacological study of novel ruthenium(III) complexes with imidazole and benzimidazole derivatives.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Burkitt Lymphoma; Cell Survival; Chemical Phenomena; Chemistry, Physical; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indicators and Reagents; Lethal Dose 50; Male; Mice; Ruthenium; Spectrophotometry, Infrared; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Substituents effect on the spectral studies on rutheninum(III) complexes of 5(-4'-derivatives phenyldiazo)-3-phenyl-2-thioxo-4-thiazolidinone.
Topics: Chemical Phenomena; Chemistry, Physical; Electrochemistry; Hydrogen Bonding; Ligands; Magnetics; Organometallic Compounds; Rhodanine; Ruthenium; Spectrophotometry, Infrared; Thiazoles | 2002 |
Synthesis, X-ray diffraction structures, spectroscopic properties, and in vitro antitumor activity of isomeric (1H-1,2,4-triazole)Ru(III) complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Organometallic Compounds; Ruthenium; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles; Triazoles | 2003 |
Ruthenium(II) sulfoxide-maltolato and -nitroimidazole complexes: synthesis and MTT assay.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Nitroimidazoles; Organometallic Compounds; Pyrones; Ruthenium; Stereoisomerism; Sulfoxides; Tetrazolium Salts; Thiazoles | 2003 |
Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A.
Topics: Algorithms; Animals; Antineoplastic Agents; Crystallography, X-Ray; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Humans; Kinetics; Models, Molecular; Organometallic Compounds; Ruthenium; Stereoisomerism; Thiazoles; Tumor Cells, Cultured | 2004 |
Complexes of ruthenium(III) with some 2-aminothiazole derivatives/synthesis, properties and pharmacological studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Electron Spin Resonance Spectroscopy; Humans; Indicators and Reagents; Lethal Dose 50; Ligands; Magnetic Resonance Spectroscopy; Ruthenium; Spectrophotometry, Infrared; Temperature; Tetrazolium Salts; Thiazoles | 2004 |
Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.
Topics: alpha-Tocopherol; Animals; Benzimidazoles; Benzoxazines; Blotting, Northern; Blotting, Western; Calcium Channel Blockers; Calcium Channels; Capsaicin; Cell Count; Cell Death; Cell Lineage; Dizocilpine Maleate; DNA, Single-Stranded; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Excitatory Amino Acid Agonists; Immunohistochemistry; In Situ Nick-End Labeling; Morpholines; N-Methylaspartate; Naphthalenes; Neurons; Neuroprotective Agents; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA, Messenger; Ruthenium; Tetrazolium Salts; Thiazoles; TRPC Cation Channels | 2005 |
Structure-function relationships within Keppler-type antitumor ruthenium(III) complexes: the case of 2-aminothiazolium[trans-tetrachlorobis(2-aminothiazole)ruthenate(III)].
Topics: Animals; Antineoplastic Agents; Crystallography, X-Ray; Leukemia P388; Molecular Conformation; Organometallic Compounds; Ruthenium; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2005 |
fac-{Ru(CO)3}2+-core complexes and design of metal-based drugs. synthesis, structure, and reactivity of Ru-thiazole derivative with serum proteins and absorption-release studies with acryloyl and silica hydrogels as carriers in physiological media.
Topics: Algorithms; Animals; Apoproteins; Cattle; Crystallography, X-Ray; Drug Design; Humans; Hydrogels; Macromolecular Substances; Molecular Structure; Organometallic Compounds; Ruthenium; Serum Albumin, Bovine; Silicon Dioxide; Solubility; Thiazoles; Transferrin; Water | 2007 |
Total synthesis of (-)-archazolid B.
Topics: Catalysis; Indicators and Reagents; Macrolides; Myxococcales; Ruthenium; Stereoisomerism; Thiazoles | 2007 |
Synthesis and activity of ruthenium olefin metathesis catalysts coordinated with thiazol-2-ylidene ligands.
Topics: Alkenes; Catalysis; Crystallography, X-Ray; Cyclization; Hydrocarbons; Ligands; Methane; Molecular Structure; Organometallic Compounds; Ruthenium; Thiazoles | 2008 |
Efficient total synthesis of dysidenin, dysidin, and barbamide.
Topics: Alkylation; Catalysis; Hydrocarbons, Chlorinated; Pyrrolidinones; Ruthenium; Stereoisomerism; Thiazoles | 2011 |
Solid-phase synthesis of peptide thioureas and thiazole-containing macrocycles through Ru-catalyzed ring-closing metathesis.
Topics: Catalysis; Cyclization; Macrocyclic Compounds; Peptides; Ruthenium; Solid-Phase Synthesis Techniques; Thiazoles; Thiourea | 2014 |
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cymenes; Female; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ovarian Neoplasms; Ruthenium; Thiazoles; Transcriptome | 2015 |
Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
Topics: Amyloid beta-Peptides; Animals; Benzothiazoles; Circular Dichroism; Fluorescence; Humans; Light; Microscopy, Atomic Force; Oxidation-Reduction; PC12 Cells; Protein Aggregates; Protein Structure, Secondary; Rats; Ruthenium; Singlet Oxygen; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazoles | 2018 |
Synthesis of 2-Arylbenzothiazole and 2-Arylthiazole Derivatives via a Ru-Catalyzed
Topics: Benzothiazoles; Catalysis; Humans; Molecular Structure; Nitrates; Ruthenium; Stereoisomerism; Thiazoles; Trypanocidal Agents; Trypanosomiasis, African | 2019 |
Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Ligands; Microscopy, Electron, Transmission; Peptide Fragments; Protein Aggregates; Rats; Ruthenium; Structure-Activity Relationship; Thiazoles | 2020 |